Since January 1st 2019, as the Nanotechnology Reviews journal has been transformed to an Open Access model, there is only one Issue per Volume, and all the published manuscripts are continuously added to the to the same, current Issue in the actual Volume.
Extensive outreach of Nanotechnology Reviews (NTREV) in the academic world
Interdisciplinary approach to Nanoscience and Nanotechnology
Innovative and pioneering contributions bringing you up to date
Critical and exhaustive approach to potential technologies
International, authoritative and topnotch editors and reviewers boosting the prestige of published papers
The Nanotechnology Reviews journal aims to promptly provide a forum of scientific information involving all aspects of nano science or nano engineering. The aim is to narrow the gap between pure science and engineering aspects of nanotechnology. The emphasis is on hot or emerging innovative topics of all areas of engineering science at the nanoscale, but in particular, nano-energy, nano-biomaterials, and nano-composites. The journal emphasizes interdisciplinary and multi-functional research and linkage between Nano Technology and Composites Technology. The scope of nanotechnology is expanding everyday. Thus, non-nano papers with potential significant future contributions to nano research may be welcomed on a case by case basis. These topics include, bio-inspired/soft materials, 3D/4D printing, molecular dynamics/multi-scale modeling, imaging, batteries, graphene/carbon nano tubes, nano-mechanics, among many others. The authors are encouraged to discuss the critical unresolved issues on nano-engineered materials, and all research results and conclusions must be substantiated by experiments and mathematical modeling. This journal welcomes both regular and review articles.
Call for papers for the 28th International Conference on Composites or Nano Engineering, ICCE-28 July 19-25, 2020 in Prague, Czech Republic Please see the Conference webpage for details: www.icce-nano.org
5-year Impact Factor
SCImago Journal Rank
Scource Normalized Impact per Paper
Abstracting & Indexing
Nanotechnology Reviews is covered by the following services:
Chemical Abstracts Service (CAS) - CAplus
Chemical Abstracts Service (CAS) - SciFinder
CNKI Scholar (China National Knowledge Infrastructure)
CNPIEC - cnpLINKer
EBSCO (relevant databases)
EBSCO Discovery Service
Japan Science and Technology Agency (JST)
Journal Citation Reports/Science Edition
KESLI-NDSL (Korean National Discovery for Science Leaders)
Norwegian Register for Scientific Journals, Series and Publishers
Primo Central (ExLibris)
ProQuest (relevant databases)
QOAM (Quality Open Access Market)
TEMA Technik und Management
Ulrich's Periodicals Directory/ulrichsweb
Web of Science - Current Contents/Physical, Chemical and Earth Sciences
Informed consent The protection of privacy is a legal right that must not be infringed without individual informed consent. In cases where the identification of personal information is necessary for scientific reasons, authors should obtain full documentation of informed consent, including written permission from the patient or their legal guardians prior to inclusion in the study. The following (or similar) statement should be included in the Materials and methods section: Informed consent was obtained from all individuals included in this study.
Authorization for the use of human subjects Manuscripts containing information related to human use should clearly state that the research complies with all relevant national regulations and institutional policies and has been approved by the authors' Institutional Review Board or any equivalent Committee. Copies of the guidelines and policy statements must be available for review by the Managing Editor if necessary. The editors reserve the right to seek additional information or guidance from reviewers on any cases in which concerns arise. All investigations with human subjects must have been conducted by following the tenets of the Declaration of Helsinki, what is more authors must identify the committee or review board approving the experiments, and provide a statement indicating approval of the research. The following (or similar) statement should be included in the Methods section: Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors' institutional review board or equivalent committee.
Authorization for the use of experimental animals Manuscripts containing information related to animals use should clearly state that the research has complied with all relevant national regulations and institutional policies and has been approved by the authors' institutional review board or equivalent committee. Copies of the guidelines and policy statements must be available for review by the Managing Editor if necessary. The editors reserve the right to seek additional information or guidance from reviewers on any cases in which concerns arise. The research using animal subjects should be conducted according to the Principles of Laboratory Animal Care and similar documents (e.g. NIH). For manuscripts reporting experiments on live vertebrates or higher invertebrates, authors must identify the committee approving the experiments, and must confirm that all experiments were performed in accordance with relevant regulations. The following (or similar) statement should be included in the Methods section: Ethical approval: The research related to animals use has been complied with all the relevant national regulations and institutional policies for the care and use of animals.
If the manuscript does not contain any study that requires human or animal ethical approval, the following statement should be included in the Methods section: Ethical approval: The conducted research is not related to either human or animals use.
Conflict of interest and author contributions A conflict of interest for a given manuscript exists when a participant in the peer review and publication process – author, reviewer, and editor – has ties to activities that could inappropriately influence his or her judgment, regardless of whether judgment is, in fact, affected. Financial relationships with industry (for example, employment, consultancies, stock ownership, honoraria, expert testimony), either directly or through immediate family, are usually considered the most important conflicts of interest. However, conflicts can occur for other reasons, such as financial support of the study, ties to health insurance, politics or other stakeholders, personal relationships, academic competition, and intellectual passion. To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest (financial, personal or professional) in connection with the manuscript under evaluation. This must be declared during the submission process and also at the end of the the manuscript. If you have no declaration to make, please insert None declared. The below mentioned statement should be included before the Reference section (or after the Acknowledgments section, if applicable). Authors must also declare responsibility for the entire content of the manuscript and may declare individual contributions of each author, if applicable.
Manuscripts must be written in clear and concise English
We look forward to receiving your manuscript!
Editor-in-chief David Hui, University of New Orleans, USA; E-mail: email@example.com
Editorial Board Alberto Bianco, Immunology, Immunopathology and Therapeutic Chemistry, I2CT, CNRS, France Katerinqa Chlichlia, Democritus University of Thrace, Alexandroupolis, Greece Xiaowei Deng, University of Hong Kong Jitang Fan, Beijing Institute of Technology, China Mizi Fan, Brunel University, UK Daining Fang, Beijing Univ.Tech., China Jiyang Fu, Guangzhou University, China Milan Gaff, Czech University of Life Sciences Prague Lizeng Gao, Institute of Biophysics, Beijing, China Wei Gao, University of New South Wales, Australia Michal M. Godlewski, Warsaw University of Life Sciences, Poland Linxia Gu, Florida Institute of Technology, USA Hamdi Bin Abd Shukor, Universiti Kebangsaan Malaysia Weidong He, UESTC, Chengdu, China Soon Hyung Hong, KAIST, South Korea Xian Jian, UESTC, Chengdu, China Denvid Lau, City University, Hong Kong Jinyang Li, Southwest Jiaotong University, China Haibao Lv, Harbin Institute of Technology, China Fanbin Meng, Southwest Jiaotong University, China K.Y. Rhee, Kyung Hee University , Yongin, S. Korea Jong Il Song, Changwon Nat. U., S. Korea K.X. Song, Henan University of Science and Technology, Luoyang, China Mohammad Talha, Indian Inst.Tech., Mandi C.P. Tsui, Hong Kong Polytechnic University Guannan Wang, Zhejiang University, China Nan Wu, University of Manitoba, Canada Feng Xing, Shenzhen Univ., China Yumin Yang, Nantong University, Jiangsu, China Chunwei Zhang, Qingdao University of Technology, China He Zhang, Zhejiang University, Hangzhou, China Changchun Zhou, Sichuan University, China Zuowan Zhou, Southwest Jiaotong University, China Jackie Yi-Ru Ying, NanoBio Laboratory, Singapore
Advisory Board Aurelio L. Araujo, University of Lisbon, Portugal Philippe Boisse, University of Lyon, France Monssef Drissi-Habti, IFSTTAR, Nantes, France Viktor Gribniak, VGTU, Vilnius, Lithuania A.H. Sofiyev, Suleyman Demirel University, Isparta, Turkey Lubomir Lapcik, Tomas Bata University in Zlin, Czech Rep. Ahmad Mujahid Ahmad Zaidi NDUM, Kuala Lumpur, Malaysia Theodoros C. Rousakis, D.U.Th., Xanthi, Greece Kun Zhang, Donghua University, Shanghai, China Jianren Zhou, Prairie View A&M University, Texas, USA